Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies.

The many faces of tau. Neuron (2011) 2.89

Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain (2007) 2.58

The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.93

Rates of cerebral atrophy differ in different degenerative pathologies. Brain (2007) 1.90

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies. Nat Rev Neurosci (2013) 1.82

Neuropsychological assessment of dementia. Annu Rev Psychol (2009) 1.76

Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol (2009) 1.73

Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies. Mov Disord (2011) 1.73

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology (2010) 1.58

Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. Neurology (2005) 1.52

Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol (2008) 1.52

Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol (2008) 1.45

Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol (2006) 1.42

Multimodality imaging characteristics of dementia with Lewy bodies. Neurobiol Aging (2011) 1.40

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia. Brain (2006) 1.25

Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies. Neurology (2009) 1.19

Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol (2013) 1.11

Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. Neuropsychology (2008) 1.03

What can biomarkers tell us about cognition in Parkinson's disease? Mov Disord (2014) 1.03

Anosmia is very common in the Lewy body variant of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 0.99

(123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review. J Mov Disord (2015) 0.95

Molecular pathology of Lewy body diseases. Int J Mol Sci (2009) 0.93

Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (Vienna) (2014) 0.92

Can we clinically diagnose dementia with Lewy bodies yet? Transl Neurodegener (2013) 0.92

The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design. Neurol Sci (2016) 0.90

Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol Aging (2014) 0.89

PET/CT in diagnosis of dementia. Ann N Y Acad Sci (2011) 0.89

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies. J Neural Transm (Vienna) (2006) 0.88

Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis? J Neural Transm (Vienna) (2007) 0.87

Abnormal P600 word repetition effect in elderly persons with preclinical Alzheimer's disease. Cogn Neurosci (2013) 0.85

Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease. Parkinsonism Relat Disord (2012) 0.84

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies. Int J Alzheimers Dis (2012) 0.83

Dementia with Lewy bodies. Neurol Clin (2007) 0.83

UPDATE ON DEMENTIA WITH LEWY BODIES. Curr Transl Geriatr Exp Gerontol Rep (2013) 0.81

Dementia with Lewy bodies. Dialogues Clin Neurosci (2004) 0.80

Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging. J Alzheimers Dis (2013) 0.80

Visual hallucinations in dementia: a prospective community-based study with autopsy. Am J Geriatr Psychiatry (2009) 0.79

Extrapyramidal signs by dementia severity in Alzheimer disease and dementia with Lewy bodies. Alzheimer Dis Assoc Disord (2013) 0.79

Dementia with Lewy bodies: improving diagnostic criteria. Neurology (2003) 0.79

Biomarkers in biological fluids for dementia with Lewy bodies. Alzheimers Res Ther (2014) 0.78

Accounting for functional loss in Alzheimer's disease and dementia with Lewy bodies: beyond cognition. Alzheimers Dement (2013) 0.78

Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutation. Cogn Behav Neurol (2008) 0.78

Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load. Neurology (2014) 0.78

Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology (2004) 0.77

Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies. Dement Geriatr Cogn Disord (2012) 0.77

Disease-modifying therapeutic directions for Lewy-Body dementias. Front Neurosci (2015) 0.76

Bridging molecular genetics and biomarkers in lewy body and related disorders. Int J Alzheimers Dis (2011) 0.76

Network dysfunction in α-synuclein transgenic mice and human Lewy body dementia. Ann Clin Transl Neurol (2015) 0.76

The role of I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies. Neuropsychiatr Dis Treat (2007) 0.75

Differentiating between visual hallucination-free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and perfusion single-photon emission computed tomography. Alzheimers Res Ther (2014) 0.75

Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis. Int J Geriatr Psychiatry (2014) 0.75

Neuropsychological Differences Related to Age in Dementia with Lewy Bodies. Dement Geriatr Cogn Dis Extra (2017) 0.75

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med (1997) 7.56

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 7.51

Conservation conflicts across Africa. Science (2001) 7.09

Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science (1995) 6.58

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. N Engl J Med (1992) 5.93

UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull (2001) 5.89

Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 4.31

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA (2000) 3.99

Reduction of environmental tobacco smoke exposure among asthmatic children: a controlled trial. Chest (1994) 3.89

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology (1990) 3.79

Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74

Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci (1997) 3.61

Distance between homes and exercise facilities related to frequency of exercise among San Diego residents. Public Health Rep (1990) 3.57

Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology (1997) 3.53

Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci (2000) 3.40

Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology (2001) 3.30

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23

Ethnic, socioeconomic, and sex differences in physical activity among adolescents. J Clin Epidemiol (1996) 3.06

Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol (1992) 3.04

Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry (2001) 2.95

A validation study of the Dementia Questionnaire. Arch Neurol (1994) 2.89

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology (2000) 2.76

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry (2001) 2.74

Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci (1988) 2.73

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology (1995) 2.69

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol (1995) 2.62

Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol (1997) 2.60

Late-onset schizophrenia: an overview. Schizophr Bull (1988) 2.58

Social skills performance assessment among older patients with schizophrenia. Schizophr Res (2001) 2.53

A comparative study of the psychosocial assets of adults with cystic fibrosis and their healthy peers. Chest (1990) 2.52

Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol (2000) 2.37

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology (2011) 2.35

Predictors of adoption and maintenance of vigorous physical activity in men and women. Prev Med (1992) 2.26

In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology (2007) 2.24

Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol (1990) 2.24

Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry (2000) 2.19

Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology (2005) 2.18

Neocortical cell counts in normal human adult aging. Ann Neurol (1987) 2.16

Rehabilitation of hemiparesis after stroke with a mirror. Lancet (1999) 2.13

Acute ascending necrotizing myelopathy caused by herpes simplex virus type 2. Neurology (1987) 2.11

Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology (2000) 2.10

Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry (2000) 2.04

Enhancing informed consent for research and treatment. Neuropsychopharmacology (2001) 2.04

Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology (1997) 2.01

Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol (1997) 2.00

Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology (1998) 1.96

Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS (2000) 1.93

Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology (2000) 1.91

Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol (1994) 1.90

Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett (1989) 1.89

The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology (1993) 1.89

Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Arch Gen Psychiatry (1995) 1.88

The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology (2004) 1.87

A multivariate study of determinants of vigorous exercise in a community sample. Prev Med (1989) 1.86

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry (1999) 1.86

Effect of counselling mothers on their children's exposure to environmental tobacco smoke: randomised controlled trial. BMJ (2000) 1.85

Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature (1993) 1.85

Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol (2001) 1.84

Depressive symptoms in schizophrenia. Am J Psychiatry (1999) 1.83

Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.80

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology (2008) 1.80

Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol (1987) 1.78

Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc (1996) 1.78

Correlates of change in walking for exercise: an exploratory analysis. Res Q Exerc Sport (1992) 1.77

Identifying correlates of walking for exercise: an epidemiologic prerequisite for physical activity promotion. Prev Med (1989) 1.76

Cognitive training in Alzheimer's disease: a meta-analysis of the literature. Acta Psychiatr Scand (2006) 1.75

Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol (2001) 1.75

Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology (2004) 1.74

Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology (2002) 1.74

Correlates of vigorous exercise in a predominantly low SES and minority high school population. Prev Med (1994) 1.72

Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. Am J Respir Crit Care Med (2000) 1.71

Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry (1989) 1.69

Diagnostic accuracy of dementia with Lewy bodies. Arch Neurol (2000) 1.69

Essential role of neocortical acetylcholine in spatial memory. Nature (1995) 1.68

Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy? Ann Neurol (1991) 1.67